BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21336725)

  • 1. Inhibitory effect of endostar in combination with radiotherapy in a mouse model of human CNE2 nasopharyngeal carcinoma.
    Zhou N; Hu G; Mei Q; Qiu H; Long G; Chen C; Guoqing H
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):62-66. PubMed ID: 21336725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.
    Wu H; Deng J; Yu S; Wang X; Chen Y
    J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):108-12. PubMed ID: 20155466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.
    Wen QL; Meng MB; Yang B; Tu LL; Jia L; Zhou L; Xu Y; Lu Y
    Cancer Sci; 2009 Aug; 100(8):1510-9. PubMed ID: 19459845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
    Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
    PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
    Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
    PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.
    Jia Y; Liu M; Huang W; Wang Z; He Y; Wu J; Ren S; Ju Y; Geng R; Li Z
    Pathol Oncol Res; 2012 Apr; 18(2):315-23. PubMed ID: 21938482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model.
    Jia Y; Liu M; Cao L; Zhao X; Wu J; Lu F; Li Y; He Y; Ren S; Ju Y; Wang Y; Li Z
    Eur J Gynaecol Oncol; 2011; 32(3):316-24. PubMed ID: 21797125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model.
    Xu Z; Zhao X; Shu H; Luo W; Dong Y; Xu L; Zhu H; Zhao Q; Lv Y
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):238. PubMed ID: 36042171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
    Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
    Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
    Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endostar reduces the growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer].
    Jia YT; Li ZX; Liu M; Chen SA; Zhang L; Wang YD
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):254-7. PubMed ID: 19615276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice.
    You Q; Kong LJ; Li FD; Wang HY; Liu DG; Pei FH; Song JT; Xu J; Chen J
    Mol Med Rep; 2015 Oct; 12(4):5594-600. PubMed ID: 26239504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study of Endostar injection concomitant with cryoablation on lung adenocarcinoma A549 xenografts.
    Ma CH; Jiang R; Li JD; Wang B; Sun LW; Lv Y
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6697-701. PubMed ID: 24377591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
    Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
    Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin Administered in Combination with Glu-GNPs Induces Radiosensitivity in Transplanted Tumor MDA-MB-231-luc Cells in Nude Mice.
    Li M; Lin L; Guo T; Wu Y; Lin J; Liu Y; Yang K; Hu C
    Biomed Res Int; 2021; 2021():9262453. PubMed ID: 34825004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth.
    Zhang K; Wang Y; Yu X; Shi Y; Yao Y; Wei X; Ma X
    BMC Cancer; 2017 Dec; 17(1):899. PubMed ID: 29282026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models.
    Zhou J; Wang L; Xu X; Tu Y; Qin S; Yin Y
    Oncol Lett; 2012 Nov; 4(5):976-980. PubMed ID: 23162635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
    Deng G; Zhao DL; Li GC; Yu H; Teng GJ
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
    Cui Y; Liu H; Liang S; Zhang C; Cheng W; Hai W; Yin B; Wang D
    Oncotarget; 2016 May; 7(19):27243-54. PubMed ID: 27029065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.